# A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years

> **NCT06210737** · PHASE4 · COMPLETED · sponsor: **Beijing Minhai Biotechnology Co., Ltd** · enrollment: 621 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **BIOLOGICAL:** PCV13
- **BIOLOGICAL:** PCV13
- **BIOLOGICAL:** PCV13
- **BIOLOGICAL:** PCV13

## Key facts

- **NCT ID:** NCT06210737
- **Lead sponsor:** Beijing Minhai Biotechnology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-26
- **Primary completion:** 2022-11-13
- **Final completion:** 2022-11-13
- **Target enrollment:** 621 (ACTUAL)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06210737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06210737, "A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06210737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*